Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Research Grade Levilimab | Login | Research Grade Levilimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Vobarilizumab | Login | Research Grade Vobarilizumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Rinucumab | Login | Research Grade Rinucumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Ganitumab | Login | Research Grade Ganitumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Cixutumumab | Login | Research Grade Cixutumumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Figitumumab | Login | Research Grade Figitumumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Istiratumab | Login | Research Grade Istiratumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Andecaliximab | Login | Research Grade Andecaliximab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Emibetuzumab | Login | Research Grade Emibetuzumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Onartuzumab | Login | Research Grade Onartuzumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Telisotuzumab | Login | Research Grade Telisotuzumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Farletuzumab | Login | Research Grade Farletuzumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Mirvetuximab | Login | Research Grade Mirvetuximab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Imalumab | Login | Research Grade Imalumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Datopotamab | Login | Research Grade Datopotamab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Valanafusp Alfa | Login | Research Grade Valanafusp Alfa | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human IL8/CXCL8 Antibody (HuMax-IL8) | Login | Research Grade Anti-Human IL8/CXCL8 Antibody (HuMax-IL8) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human IL8/CXCL8 Antibody (ABX-IL8) | Login | Research Grade Anti-Human IL8/CXCL8 Antibody (ABX-IL8) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD54/ICAM1 Antibody (MOR101) | Login | Research Grade Anti-Human CD54/ICAM1 Antibody (MOR101) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD54/ICAM1 Antibody (MOR102) | Login | Research Grade Anti-Human CD54/ICAM1 Antibody (MOR102) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD66e/CEA/CEACAM5 Antibody (cT84.66) | Login | Research Grade Anti-Human CD66e/CEA/CEACAM5 Antibody (cT84.66) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Ibritumomab | Login | Research Grade Ibritumomab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Bevacizumab | Login | Research Grade Bevacizumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Natalizumab | Login | Research Grade Natalizumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Ranibizumab | Login | Research Grade Ranibizumab | ||||||||||||||||
|